JOHNSON & JOHNSON TALCUM POWDER PRODUCTS MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION

Track this case

Case Number:

3:16-md-02738

Court:

New Jersey

Nature of Suit:

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Multi Party Litigation:

Multi-district Litigation

Judge:

Freda L. Wolfson

Firms

Companies

Government Agencies

Sectors & Industries:

  1. December 20, 2023

    Beasley Allen Atty Slams J&J's 'Locker-Room Brawl' DQ Bid

    Beasley Allen Law Firm and one of its veteran plaintiffs' attorneys have hit back at Johnson & Johnson's attempt to disqualify them from multidistrict litigation over the alleged link between the company's talcum powder products and ovarian cancer, denying that they collected privileged information from a former J&J attorney.

  2. June 17, 2021

    Cosmetics Trade Group Escapes J&J Asbestos-In-Talc MDL

    New Jersey's top federal judge has tossed claims against a nonprofit cosmetics trade association in multidistrict litigation over the alleged link between Johnson & Johnson's talcum powder products and ovarian cancer, finding that the group does not have a "legal duty to consumers" to make sure the products are safe.

  3. April 27, 2020

    J&J Can't Boot Experts To Sink Asbestos-In-Talc MDL

    A New Jersey federal judge on Monday largely rejected Johnson & Johnson's efforts to bar plaintiffs' experts from testifying that J&J's baby powder contains asbestos and that talc can cause ovarian cancer, opening a path to trials in the multidistrict litigation that contains thousands of cases.

  4. September 20, 2019

    J&J's Litigation Bravado In Sharp Relief After Epic Opioid Trial

    Johnson & Johnson's decision this year to risk a $17 billion penalty in the nation's first opioid-crisis trial added one of the most dramatic chapters yet to the company's increasingly remarkable willingness to spurn settlements and litigate financially perilous cases all the way.

  5. July 22, 2019

    Test Tube Cancer Research Beats Animal Studies, J&J Hears

    An ovarian cancer researcher defended his use of test-tube experiments instead of animal studies to examine the purported link between the disease and Johnson & Johnson's talcum powder, telling a New Jersey federal court Monday that his method was the "gold-standard" in the industry despite opinions otherwise. 

  6. July 15, 2019

    J&J Slams 'Gross Mischaracterization' Of Talc Ruling

    Consumers alleging Johnson & Johnson's talcum powder causes cancer have "grossly" mischaracterized a California state appellate court's finding in one woman's case by stating that the court overturned a ruling on general causation, the pharmaceutical giant fumed Monday in a filing in the ongoing multidistrict litigation.

  7. December 21, 2017

    Where 5 Top MDLs Stand At The End Of 2017

    Multidistrict litigation dockets sizzled in 2017 with a spate of notable bellwether trials and a handful of attention-grabbing settlements, as well as centralization of litigation over some of the year's biggest corporate scandals.

  8. September 12, 2017

    Special Master To Oversee Discovery In J&J Talc MDL

    A New Jersey federal court on Monday detailed a retired judge's responsibilities as special master overseeing discovery in multidistrict litigation alleging Johnson & Johnson's talc-based products cause ovarian and uterine cancer.

  9. August 28, 2017

    J&J Says Talc Samples Would Run Out In MDL

    Johnson & Johnson on Friday told the New Jersey judge overseeing multidistrict litigation over its allegedly dangerous talcum powder products that there are limited amounts of "historical" products related to the litigation, and they'll run out of they're distributed on a "first come, first served" basis.

  10. August 24, 2017

    Women In J&J Talc MDL Say They Should Get Samples

    Women in multidistrict litigation in New Jersey alleging Johnson & Johnson talcum powder products cause ovarian and uterine cancer on Wednesday said that they should be allowed to obtain samples of the products, saying there's no proof they will be destroyed in testing.